Patient Preferences for Treatment in Testicular Cancer
Author Information
Author(s): MH Cullen, LJ Billingham, J Cook, CM Woodroffe
Primary Institution: Birmingham Oncology Centre, University Hospital, Birmingham NHS Trust
Hypothesis
What management approach do patients prefer for stage I non-seminomatous germ cell tumours of the testis?
Conclusion
Patients show a wide variability in treatment preferences, often favoring options they have prior experience with.
Supporting Evidence
- 207 subjects participated in the study across nine different groups.
- Patients with prior experience tended to favor the treatment they had received.
- 44% of newly diagnosed patients preferred the doctor to decide on treatment.
Takeaway
This study asked cancer patients how they would choose between two treatment options, and found that many want their doctor to help decide.
Methodology
Questionnaires were distributed to various groups including newly diagnosed patients and oncologists to assess treatment preferences based on hypothetical recurrence risks.
Potential Biases
Potential bias due to the presence of a research nurse who administered the questionnaires.
Limitations
The study's findings may not be generalizable beyond the specific populations surveyed.
Participant Demographics
Participants included newly diagnosed patients, patients with prior treatment experience, medical students, firemen, and oncologists.
Statistical Information
P-Value
0.06
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website